Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.


Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >

Follow Us on Twitter

Alexandra Whitney's Twitter avatar
Alexandra Whitney

Getting Help For My Postpartum Depression | NAMI: National Alliance on Mental Illness t.co/7S0wczBkC7 via… t.co/oqnp9hSc9v

Retweeted by Marinus Pharma